COSMOS Pharmaceutical (TSE:3349) Interest Expense : 円-70 Mil (TTM As of Feb. 2024)

View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. COSMOS Pharmaceutical's interest expense for the three months ended in Feb. 2024 was 円 -18 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2024 was 円-70 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. COSMOS Pharmaceutical's Operating Income for the three months ended in Feb. 2024 was 円 7,902 Mil. COSMOS Pharmaceutical's Interest Expense for the three months ended in Feb. 2024 was 円 -18 Mil. COSMOS Pharmaceutical's Interest Coverage for the quarter that ended in Feb. 2024 was 439.00. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

COSMOS Pharmaceutical Interest Expense Historical Data

The historical data trend for COSMOS Pharmaceutical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Interest Expense Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Interest Expense

Get a 7-Day Free Trial

-77.00

-69.00

-60.00

-52.00

-51.00

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Interest Expense	Get a 7-Day Free Trial															-11.00	-17.00	-18.00	-17.00	-18.00

COSMOS Pharmaceutical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-70 Mil.

COSMOS Pharmaceutical (TSE:3349) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

COSMOS Pharmaceutical's Interest Expense for the three months ended in Feb. 2024 was 円-18 Mil. Its Operating Income for the three months ended in Feb. 2024 was 円7,902 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2024 was 円7,962 Mil.

COSMOS Pharmaceutical's Interest Coverage for the quarter that ended in Feb. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Feb. 2024 )	/	Interest Expense (Q: Feb. 2024 )
	=	-1	*	7902	/	-18
	=	439.00

The higher the ratio, the stronger the company's financial strength is.

COSMOS Pharmaceutical (TSE:3349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines